Belgia - englanti - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pharmathen s.a. - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; latanoprost 50 µg/ml - eye drops, solution - 50 µg/ml - 5 mg/ml - latanoprost 50 µg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

Kanada - englanti - Health Canada

generic medical partners inc - latanoprost; timolol (timolol maleate) - solution - 50mcg; 5mg - latanoprost 50mcg; timolol (timolol maleate) 5mg - beta-adrenergic agents

Australia - englanti - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate; benzalkonium chloride; water for injections; monobasic sodium phosphate monohydrate - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Australia - englanti - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - latanoprost -

Kanada - englanti - Health Canada

mantra pharma inc - latanoprost; timolol (timolol maleate) - solution - 50mcg; 5mg - latanoprost 50mcg; timolol (timolol maleate) 5mg - beta-adrenergic agents

Australia - englanti - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: purified water; benzalkonium chloride; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - latanoprost 0.05 mg/ml; timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol - eye drops, solution - active: latanoprost 0.05 mg/ml timolol maleate 6.83 mg/ml equivalent to 5 mg/ml timolol excipient: benzalkonium chloride dibasic sodium phosphate hydrochloric acid monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide water for injection - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol sandoz 50/5 should not be used to initiate therapy.

Yhdistynyt kuningaskunta - englanti - myHealthbox

tubilux pharma - latanoprost, timolol - eye drops - 50 micrograms/ml + 5 mg/ml - ophthalmological-betablocking agents - timolol, combinations - reduction of intraocular pressure (iop) in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; benzalkonium chloride; dibasic sodium phosphate; water for injections; sodium chloride; hydrochloric acid; monobasic sodium phosphate monohydrate - the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanocom should not be used to initiate therapy.

Malesia - englanti - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma (m) sdn. bhd. - latanoprost; timolol maleate -